Legacy Acquisition Corp. (LGC), announced this morning that they intend to adjourn their shareholder vote to combine with Blue Impact, originally scheduled to be held this Thursday, April 23rd. The new date will be Monday, May 18, 2020, while keeping the record date of March 20, 2020. More importantly, the reason for the adjournment was stated as, “intended to provide additional time required for Legacy to complete its potential PIPE financing with both new and current investors in advance of the Special Meeting.“
For reference, last month on March 13th, Legacy announced an amendment to their Share Exchange agreement with Blue Impact, as a direct response to the “recent dislocation in the equity markets“. The re-struck deal resulted in an adjustment to the enterprise value of approximately $33 million ($559 million, down from $592 million). Additionally, Legacy announced a proposal to amend their public warrants whereby warrant holders would receive $1.00 cash for each whole warrant if the amendment is approved. However, warrant holders will receive $1.00 in cash if the aggregate gross cash proceeds after redemptions is at least $225 million. If it’s less than $225 million, warrant holders will receive $0.50, but they will also receive 0.055 shares of common stock per warrant.
Legacy also intends to get a $75.0 million PIPE financing at $10.00, but given today’s announcement, sounds like it’s not a done deal yet. Keep in mind that Legacy does not have the Crescent Term. We’ll have to wait and see if any further changes are announced ahead of the new May 18, 2020 vote date.
Overall deal flow between SPACs and biotech firms has slowed over the last year, but some pending FDA changes could breathe new life into particular business models within the space. In particular, the FDA has asked Congress as part of its 2025 Legislative Proposals to eliminate the interchangeability designation for biosimilar medications, claiming the existing...
At the SPAC of Dawn Ever since Digital World announced its combination with Trump Media (NASDAQ:DJT) back in October 2021, it was clear that SPACworld and the Trump show were set to be intertwined for quite some time. And, although not every headline has a bearing on the wider SPAC world, Trump Media’s post-close rise...
AltC (NYSE:ALCC) has reportedly been taking the pitch deck for its combination with nuclear fission firm Oklo on the road in recent weeks, which has generated the rare result of a SPAC trading significantly above its trust value still well before completing its deal. The SPAC has an estimated $10.59 per share in its trust...
Trump Media (NASDAQ:DJT) is down about -15% in the pre-market following the filing of its first S-1 since closing its combination with Digital World, and this includes the issuance of the 21,491,251 shares. Of these, 14,375,000 are to be made available for those exercising warrants while the rest would go out to note holders from...
At the SPAC of Dawn This week, bookended by the end of Ramadan and the beginning of Passover, could wind up stacked with events to avoid those holiday times, but for now SPACs have scheduled just six extension votes for this stretch. Redwood (NASDAQ:RWOD) and Genesis Growth Tech (OTC:GGAAF) have yet to release results from...